S. Harada et al., MICROSATELLITE INSTABILITY IS RARE IN THE CLINICAL COURSE OF MYELODYSPLASTIC SYNDROME STUDIED WITH DNA FROM FRESH AND PARAFFIN-EMBEDDED TISSUES, Journal of cancer research and clinical oncology, 124(5), 1998, pp. 231-235
Microsatellite instability (MSI) has been reported to occur in various
types of malignant neoplasms. We performed a polymerase-chain-reactio
n-based assay for MSI between the initial and the most recently availa
ble (''latest'') samples from 23 patients with myelodysplastic syndrom
e (MDS). Of these patients, 15 were informative at more than three mic
rosatellite loci. Seven patients showed as increase in leukemic cells
while 8 patients did not during the interval between the two analyses.
Only 1 of the patients, who had refractory anemia with excess;blasts,
which changed to acute myelogenous leukemia, showed microsatellite al
teration at the analysis times. Among all 23 patients, two alterations
were detected in the 42 informative paired samples that showed an inc
rease in leukemic cells (4.8%), while none was directed in the 59 pair
ed samples without such an increase. In total, therefore only two alte
rations were detected among 101 informative paired samples (2%). This
indicates that MSI is rare in the clinical course of MDS irrespective
of disease status, and is consequently not a critical genetic event fo
r disease progression in most MDS patients.